Location History:
- Didcot, GB (1994 - 1995)
- Oxford, GB (1997)
Company Filing History:
Years Active: 1994-1997
Title: **Anderson D. Ifill: Innovator in Pharmaceutical Science**
Introduction
Anderson D. Ifill, based in Didcot, GB, is an accomplished inventor with a remarkable portfolio of four patents. He is particularly renowned for his contributions to the field of medicinal chemistry, focusing on the development of compounds that can potentially influence serotonin receptors.
Latest Patents
Among Anderson's latest innovations, he has developed "Amide derivatives as 5-HT1A ligands" and "4-amino-2-(hetero)aryl-butanamides useful as 5-HT1A antagonists". These advancements highlight his commitment to exploring new therapeutic pathways to address various neurological disorders.
Career Highlights
Anderson currently works with John Wyeth & Brother Limited, a company that emphasizes innovation in pharmaceutical development. Throughout his career, he has consistently pushed the boundaries of research, contributing to the advancement of numerous projects aimed at creating effective treatments for patients.
Collaborations
He has collaborated with notable colleagues, including Ian A. Cliffe and Alan C. White. These partnerships have enriched his work, fostering an environment of shared knowledge and innovation that enhances the quality and impact of their research endeavors.
Conclusion
In summary, Anderson D. Ifill's dedication to pharmaceutical innovation and his impressive patent contributions underscore his significant role in advancing medicinal chemistry. His work continues to inspire future generations of researchers and inventors in the field.